38 citations
,
March 2015 in “Journal of controlled release” This study found that transfollicular delivery using surfactant-based nanoparticles significantly enhanced antigen stability and immune response compared to other delivery methods, especially when combined with an adjuvant.
4 citations
,
October 2022 in “Journal of family medicine and primary care” This study observed a high prevalence of hair loss among adults after receiving COVID-19 vaccination, with two-thirds of participants experiencing this issue and a minority of cases possibly vaccine-related.
March 2023 in “Медицинский совет” This review discusses various types of hair loss associated with COVID-19 and vaccinations, highlighting acute telogen hair loss as the most common form, but reports no new clinical results.
January 2025 in “Annals of Dermatology” In this nationwide cross-sectional study, researchers found that COVID-19 vaccination was associated with an increased risk of hair loss disorders, including total alopecia, alopecia areata, and telogen effluvium, while no significant link was observed between COVID-19 infection and these conditions.
This article discusses vaccination coverage for BCG, Polio, and Hepatitis B in Juiz de Fora using SUS data and reports no new results; the authors aim to hypothesize reasons for coverage variation.